Assessment of Immunogenicity From Galcanezumab Phase III Trials in Patients With Episodic or Chronic Migraine
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Cephalalgia: An International Journal of Headache
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Assessment of Immunogenicity From Galcanezumab Phase 3 Trials in Patients With Episodic or Chronic Migraine
Cephalalgia 2020 Apr 27;[EPub Ahead of Print], JM Martinez, N Hindiyeh, G Anglin, K Kalidas, ME Hodsdon, W Kielbasa, BA Moser, EM Pearlman, S GarcesFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.